Bruton’s tyrosine kinase (BTK) and Bcl-2 inhibitors induce ferroptosis, but only BTK inhibition sensitizes CLL cells to ferroptosis. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.